BRIACELL THERAP Total non-current liabilities

Total non-current liabilities of BCTX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Total non-current liabilities growth rates and interactive chart.


Highlights and Quick Summary

  • Total non-current liabilities for the quarter ending October 31, 2022 was $27.1 Million (a -13.3% decrease compared to previous quarter)
  • Year-over-year quarterly Total non-current liabilities increased by 10822.29%
  • Annual Total non-current liabilities for 2022 was $31.3 Million (a 5.0% increase from previous year)
  • Annual Total non-current liabilities for 2021 was $29.8 Million (a 19024.63% increase from previous year)
Visit stockrow.com/BCTX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Total non-current liabilities of BRIACELL THERAP

Most recent Total non-current liabilitiesof BCTX including historical data for past 10 years.

Interactive Chart of Total non-current liabilities of BRIACELL THERAP

BRIACELL THERAP Total non-current liabilities for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $27.14 $31.31 $0.28 $0.25 $31.31
2021 $0.33 $29.82 $6.89 $0.15 $29.82
2020 $0.15 $0.16 $0.16

Business Profile of BRIACELL THERAP

Sector: Healthcare
Industry: Biotechnology